CVS Health Corp. buy Subdi
Summary
This prediction ended on 16.07.22 with a price of €95.19. With a performance of 99.31% the BUY prediction by Subdi was a big success. A total of €6.21 was paid as dividends for this prediction. Subdi has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
CVS Health Corp. | -5.311% | -5.311% | -18.528% | -24.791% |
iShares Core DAX® | 1.395% | -0.696% | 15.472% | 15.907% |
iShares Nasdaq 100 | 2.287% | 7.501% | 34.748% | 53.474% |
iShares Nikkei 225® | 1.617% | 2.769% | 11.442% | 8.194% |
iShares S&P 500 | 0.659% | 4.280% | 26.778% | 45.322% |
Comments by Subdi for this prediction
In the thread CVS Health Corp. diskutieren
Subdi stimmt der Buy-Einschätzung von tamam zu
Subdi stimmt am 09.03.2019 der Buy-Einschätzung von tamam mit dem Kursziel 85$ zu.
Überschrift: tamam stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu
In the thread Trading CVS Health Corp.